We are live on ! Find out more
PAM

Paradigm Asset Management Portfolio holdings

AUM $426M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+18.16%
3 Year Est. Return
+51.62%
5 Year Est. Return
+67.65%
10 Year Est. Return
+240.73%
AUM
$386M
AUM Growth
-$109M
Cap. Flow
-$127M
Cap. Flow %
-32.8%
Top 10 Hldgs %
9.92%
Holding
586
New
3
Increased
10
Reduced
171
Closed
172

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$1.93M
2
AAPL icon
Apple
AAPL
+$1.58M
3
EOG icon
EOG Resources
EOG
+$1.35M
4
VLO icon
Valero Energy
VLO
+$1.33M
5
EXC icon
Exelon
EXC
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 19.58%
2 Energy 9.66%
3 Healthcare 8.69%
4 Industrials 7.3%
5 Technology 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WERN icon
401
Werner Enterprises
WERN
$2.24B
-3,300
Closed -$96.9K
WNC icon
402
Wabash National
WNC
$512M
-16,800
Closed -$369K
WST icon
403
West Pharmaceutical
WST
$24B
-600
Closed -$56.7K
WTS icon
404
Watts Water Technologies
WTS
$11.5B
-1,400
Closed -$88.5K
ZUMZ icon
405
Zumiez
ZUMZ
$332M
-7,800
Closed -$96.3K
TPC
406
Tutor Perini Cor
TPC
$4.41B
-1,700
Closed -$48.9K
NVRO
407
DELISTED
NEVRO CORP.
NVRO
-4,400
Closed -$327K
INFN
408
DELISTED
Infinera Corporation Common Stock
INFN
-18,800
Closed -$201K
ROIC
409
DELISTED
Retail Opportunity Investments Corp.
ROIC
-3,600
Closed -$69.1K
RVNC
410
DELISTED
Revance Therapeutics, Inc.
RVNC
-17,600
Closed -$465K
EGRX
411
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-1,100
Closed -$86.8K
AEL
412
DELISTED
American Equity Investment Life Holding Company
AEL
-3,500
Closed -$92K
KAMN
413
DELISTED
Kaman Corp
KAMN
-1,200
Closed -$59.8K
BFX
414
DELISTED
BowFlex Inc.
BFX
-17,700
Closed -$339K
NXGN
415
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-4,200
Closed -$72.3K
NEWR
416
DELISTED
New Relic, Inc.
NEWR
-2,000
Closed -$86K
NUVA
417
DELISTED
NuVasive, Inc.
NUVA
-700
Closed -$53.8K
PDCE
418
DELISTED
PDC Energy, Inc.
PDCE
-1,100
Closed -$47.4K
ACOR
419
DELISTED
Acorda Therapeutics
ACOR
-18
Closed -$43.3K
SJI
420
DELISTED
South Jersey Industries, Inc.
SJI
-7,900
Closed -$270K
ABMD
421
DELISTED
Abiomed Inc
ABMD
-400
Closed -$57.3K
CLVS
422
DELISTED
Clovis Oncology, Inc.
CLVS
-900
Closed -$84.3K
ZVO
423
DELISTED
Zovio Inc. Common Stock
ZVO
-6,875
Closed -$101K
PSB
424
DELISTED
PS Business Parks, Inc.
PSB
-1,700
Closed -$225K
NP
425
DELISTED
Neenah, Inc. Common Stock
NP
-800
Closed -$64.2K

Similar funds

Paradigm Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Paradigm Asset Management held 586 positions worth $386M, down 22% from $495M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Paradigm Asset Management withdrew a net $127M in Q3 2017, closing 172 positions and reducing 171 holdings. Its most notable exit was Supernus Pharmaceuticals, an estimated $668K position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Paradigm Asset Management opened a new position in Brighthouse Financial worth $464K.

  • Paradigm Asset Management's largest Q3 2017 buy was Brighthouse Financial: 7,636 shares worth $464K.
  • Paradigm Asset Management added most to Baidu in Q3 2017, an estimated $218K increase.
  • Paradigm Asset Management's biggest Q3 2017 reduction was MetLife, cutting an estimated $1.93M.
  • Paradigm Asset Management fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $668K.
  • Paradigm Asset Management's ten largest holdings make up 9.9% of its $386M portfolio in Q3 2017.
  • Paradigm Asset Management opened 3 new positions and closed 172 in Q3 2017.
  • Paradigm Asset Management's portfolio value fell 22% quarter-over-quarter to $386M.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.